MDCT helps better determine valve implant size for transcatheter aortic valve in patients with aortic stenosis

MDCT is a better way to measure annular size in patients with aortic stenosis who are candidates for transcatheter aortic valve implantation (TAVI) than two dimensional echocardiography, a new study indicates.

The study included 69 patients who underwent an MDCT scan as well as transthoracic and transesophageal before having a TAVI, said Dr. Vineeta Sethi, lead author of the study. TAVI is done to treat patients with who are not surgical candidates. Aortic stenosis is a common disorder in the elderly.

"Measurement of the aortic annulus is crucial for implant size selection and procedure success," said Dr. Sethi. "If the implanted valve is too small, blood will leak outside of the valve apparatus back into the heart."

Measurements obtained on MDCT were significantly different than those obtained on echocardiography. "The decision to use a certain valve size would have been changed in about 55% of patients in our study if MDCT measurements had been used rather than echocardiography measurements," she said. "This includes patients who were wrongly sized as well as those who would have been disqualified from having TAVI due to the large size of their aortic annulus," she added.

She also stated that transesophagea/transthoracic echocardiographically derived measurements of the aortic annulus are the current standard for measurement but with the increasing awareness of the in measurement between MDCT and echocardiography, more people are using MDCT derived measurements to choose appropriate valve size.

The study will be part of the electronic exhibit program at the ARRS Annual Meeting in Washington, DC.

Related Stories

Recommended for you

Cognitive impairment predicts worse outcome in heart failure

date May 24, 2015

Cognitive impairment predicts worse outcome in elderly heart failure patients, reveals research presented today at Heart Failure 2015 by Hiroshi Saito, a physiotherapist at Kameda Medical Centre in Kamogawa, Japan. Patients ...

1950s drug is future heart treatment

date May 22, 2015

Oxford University researchers have found a promising future treatment for heart disease, going back to a drug first developed in 1950.

Time is muscle in acute heart failure

date May 21, 2015

Urgent diagnosis and treatment in acute heart failure has been emphasised for the first time in joint recommendations published today in European Heart Journal.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.